Filter Results:
(74)
Show Results For
- All HBS Web
(119)
- News (25)
- Research (74)
- Events (1)
- Multimedia (2)
- Faculty Publications (43)
Show Results For
- All HBS Web
(119)
- News (25)
- Research (74)
- Events (1)
- Multimedia (2)
- Faculty Publications (43)
←
Page 4 of 74
Results
Sort by
- 09 Aug 2016
- First Look
August 9, 2016
spending in the United States, accounting for less than 1% of prescriptions filled but nearly 28% of drug spending. Whereas traditional (chemically synthesized, "small-molecule") View Details
Keywords: Sean Silverthorne
- 12 Jul 2020
- Research & Ideas
Solving COVID'S Mental Health Crisis
community-based organizations. COVID-19 has disrupted GPP’s school-based activities, which include teacher training and the Teen Advisory Council, a program that supports students as they educate their peers about the dangers of View Details
- 17 Sep 2001
- Research & Ideas
Why E-commerce Didn’t Die With the Fall of Webvan
drugs for chronic conditions—from pharmacies to a combination of direct mail and telephone. The idea was that if you have a chronic condition, you're in a replenishment mode. You have to fill the View Details
- 26 Jun 2000
- Research & Ideas
What’s an Internet Business Model? Ask a Health Care Professional
either." CareGroup, as an "integrated delivery group," gives patients and physicians within the network an ability to conduct a myriad of activities online. These tasks can range from refilling prescriptions to accessing personal MRI... View Details
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
screening participants in drug trials and make it possible to track and troubleshoot unexpected problems that show up after a drug is introduced into the general population, like what happened with Vioxx.... View Details
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologic drugs (therapeutic proteins or “large-molecule drugs”) represent a substantial and growing share of the U.S. drug market, accounting... View Details
Keywords: Sean Silverthorne
- 27 Sep 2011
- First Look
First Look: September 27
Even in the absence of national health coverage, the United States became the world's largest prescription drug market and emerged as the global leader in new drug research and... View Details
Keywords: Sean Silverthorne
- 12 Jul 2006
- Research & Ideas
Competition the Cure for Healthcare
the various actors in the system are not designed around value, nor is competition reinforcing improvements in value. For example, let's take the prescription drug benefit, the big reform of today that... View Details
- 12 Oct 2006
- First Look
First Look: October 12, 2006
prescriptions for companies, investors, and policymakers seeking ways to improve the industry's performance. According to Pisano, the biotech industry's problems stem from its special character as a science-based business. This character... View Details
Keywords: Sean Silverthorne
- 07 Aug 2007
- First Look
First Look: August 7, 2007
and issues around current practices. Purchase this note: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807124 U.S. Food and Drug Administration Harvard Business School Note 807-050 Describes the U.S. FDA with particular... View Details
Keywords: Martha Lagace
- 13 Sep 2011
- First Look
First Look: September 13
adequate because they possess the Invariant Proportion of Substitution (IPS) property, which imposes counter-intuitive restrictions on individual choice behavior. Indeed our empirical application to prescription writing choices of... View Details
Keywords: Sean Silverthorne
- 30 Jun 2020
- Book
Capitalism Is More at Risk Than Ever
based on those forecasts, the highlights of their observations, and prescriptive thoughts based on our analysis of their ideas. The executives identified 10 powerful forces that had the potential to disrupt the progress flowing from the... View Details
Keywords: by Martha Lagace
- 13 Jan 2009
- First Look
First Look: January 13, 2009
and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven... View Details
Keywords: Martha Lagace